Business
Appointment of joint corporate brokers
Appointment of joint corporate brokers.
About this update from Astrazeneca Plc
[{"type":"text","content":"\n \n \n 9 May 2022 13:00 BST\n \n \n \n \n \n \n \n \n \n \n \n Appointment of joint corporate brokers\n \n \n \n \n \n \n \n \n AstraZeneca PLC announced that its joint corporate brokers will be Morgan Stanley & Co. International plc and J.P. Morgan Securities plc (which conducts its UK investment banking business as J.P. Morgan Cazenove), effective as of 9 May 2022.\n \n \n \n \n \n \n \n \n AstraZeneca\n \n \n \n AstraZeneca (LSE/STO/Nasdaq: AZN) is a global, science-led biopharmaceutical company that focuses on the discovery, development, and commercialisation of prescription medicines in Oncology, Rare Diseases, and BioPharmaceuticals, including Cardiovascular, Renal & Metabolism, and Respiratory & Immunology. Based in Cambridge, UK, AstraZeneca operates in over 100 countries and its innovative medicines are used by millions of patients worldwide. Please visit\n \n astrazeneca.com\n \n and follow the Company on Twitter\n \n @AstraZeneca\n \n .\n \n \n \n \n \n \n \n \n Contacts\n \n \n \n For details on how to contact the Investor Relations Team, please click \n \n \n here\n \n \n . For Media contacts, click \n \n \n here\n \n \n .\n \n \n \n \n \n \n \n \n \n \n \n \n \n Adrian Kemp\nCompany Secretary\n \n \n \n \n AstraZeneca PLC\n \n \n \n \n \n \n ","length":3520,"tagName":"div"}]